Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough

Journal of Allergy and Clinical Immunology

Volumn 113, Issue 6, 2004, Pages 1063-1070

  Chaudhuri, Rekha ^a   McMahon, Alex D ^a   Thomson, Lorna J ^a   MacLeod, Kirsten J ^a   McSharry, Charles P ^a   Livingston, Eric ^a   McKay, Anne ^a   Thomson, Neil C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Carbon monoxide; Chronic obstructive pulmonary disease; Chronic persistent cough; CO; COPD; Cough variant asthma; CVA; Cys LT; Cysteinyl leukotriene; ECP; eNO; Eosinophilic cationic protein; Exhaled nitric oxide; inflammation; inhaled corticosteroids; mediators

Indexed keywords

CARBON MONOXIDE; CORTICOSTEROID; EOSINOPHIL CATIONIC PROTEIN; FLUTICASONE; INTERLEUKIN 8; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; MYELOPEROXIDASE; NITRIC OXIDE; PEPTIDOLEUKOTRIENE; PLACEBO; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL COUNT; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXHALATION; FEMALE; HUMAN; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; SPUTUM; STATISTICAL SIGNIFICANCE; SYMPTOM; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADMINISTRATION, INHALATION; ADULT; AGED; ANDROSTADIENES; CHRONIC DISEASE; COUGH; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; NITRIC OXIDE; SPUTUM;

EID: 3042756579     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.03.019     Document Type: Article

References (46)

1. O'Connell F. Management of persistent dry cough. Thorax. 53:1998;723-724
2. Pede C.D., Viegi G., Quackenboss J., Boyer-Pfersdorf P., Lebowitz M. Respiratory symptoms and risk factors in an Arizona population sample of Anglo and Mexican-American whites. Chest. 99:1991;916-922
3. Wynder E., Lemon F., Mantel N. Epidemiology of persistent cough. Am Rev Respir Dis. 91:1964;679-684
4. Poe R., Harder R., Israel R., Kallay M. Chronic persistent cough: experience in diagnosis and outcome using an anatomic diagnostic protocol. Chest. 95:1989;723-728
5. Pratter M., Bartter T., Akers S., DuBois J. An algorithmic approach to chronic cough. Ann Intern Med. 119:1993;977-983
6. Irwin R., Curley F., French C. Chronic Cough: The spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis. 141:1990;640-647
7. McGarvey L., Heaney L., Lawson J., Johnstone B., Scally C., Ennis M., et al. Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol. Thorax. 53:1998;738-743
8. O'Connell F., Thomas V., Pride N., Fuller R. Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med. 150:1994;374-380
9. Jatakanon A., Lalloo U., Lim S., Chung K., Barnes P. Increased neutrophils and cytokines, TNF-alpha and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax. 54:1999;234-237
10. Niimi A., Amitani R., Suzuki K., Tanaka E., Murayama T., Kuze F. Eosinophilic inflammation in cough variant asthma. Eur Respir J. 11:1998;1064-1069
11. McGarvey L., Forsyth P., Heaney L., MacMahon J., Ennis M. Bronchoalveolar lavage findings in patients with chronic nonproductive cough. Eur Respir J. 13:1999;59-65
12. Israili Z., Hall W. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med. 117:1992;234-242
13. Gibson P., Zlatic K., Scott J., Sewell W., Woolley K., Saltos N. Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol. 101:1998;320-326
14. Pavord I., Brightling C., Woltmann G., Wardlaw A. Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 353:1999;2213-2214
15. Brightling C., Monteiro W., Ward R., Parker D., Morgan M., Wardlaw A., et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 356:2000;1480-1485
16. Brightling C., Ward R., Woltmann G., Bradding P., Sheller J., Dworski R., et al. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med. 162:2000;878-882
17. Birring S.S., Parker D., Brightling C.E., Bradding P., Wardlaw A.J., Pavord I.D. Induced sputum inflammatory mediator concentration in chronic cough. Am J Respir Crit Care Med. 169:2004;15-19
18. Kharitonov S., Yates D., Barnes P. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 153:1996;454-457
19. Zayasu K., Sekizawa K., Okinaga S., Yamaya M., Ohrui T., Sasaki H. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med. 156:1997;1140-1143
20. Irwin R., Boulet L., Cloutier M., Gold P., Ing A., O'Byrne P., et al. Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest. 114:1998;133S-175S
21. Gardner R., Hankinson J., Clausen J., Crapo R. Jr., Epler G. Standardization of spirometry-1987 update, American Thoracic Society. Am Rev Respir Dis. 136:1987;1285-1298
22. Cockcroft D., Killian D., Mellon J., Hargreave F. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy. 7:1977;235-243
23. Kharitonov S., Alving K., Barnes P. Exhaled and nasal nitric oxide measurements: recommendations. Eur Respir J. 10:1997;1683-1693
24. Pin I., Gibson P., Kolendowicz R., Girgis-Gabardo A., Denburg J., Hargreave F., et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 47:1992;25-29
25. Chalmers G., MacLeod K., Thomson L., Little S., McSharry C., Thomson N. Smoking and airway inflammation in patients with mild asthma. Chest. 120:2001;1917-1922
26. Popov T., Gottschalk R., Kolendowicz R., Dolovich J., Powers P., Hargreave F. The evaluation of a cell dispersion method of sputum examination. Clin Exp Allergy. 24:1994;778-783
27. Spanevello A., Confalonieri M., Sulotto F., Romano F., Balzano G., Migliori G.B., et al. Induced sputum cellularity: reference values and distribution in normal volunteers. Am J Respir Crit Care Med. 162:2000;1172-1174
28. Keatings V., Jatakanon A., Worsdell Y., Barnes P. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 155:1997;542-548
29. Gibson P., Dolovich J., Denburg J., Ramsdale E., Hargreave F. Chronic cough: eosinophilic bronchitis without asthma. Lancet. 1:1989;1346-1348
30. Sampson A. The role of eosinophils and neutrophils in inflammation. Clin Exp Allergy. 30:(suppl 1):2000;22-27
31. Pizzichini E., Pizzichini M., Gibson P., Parameswaran K., Gleich G., Berman L., et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 158:1998;1511-1517
32. Pizzichini M., Pizzichini E., Parameswaran K., Clelland L., Efthimiadis A., Dolovich J., et al. Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J. 6:1999;323-330
33. Gibson P., Hargreave F., Girgis-Gabardo A., Morris M., Denburg J., Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy. 25:1995;127-132
34. Boulet L.-P., Milot J., Boutet M., St Georges F., Laviolette M. Airway Inflammation in nonasthmatic subjects with chronic cough. Am J Respir Crit Care Med. 149:1994;482-489
35. Davies M., Fuller P., Picciotto A., McKenzie S. Persistent nocturnal cough: randomised controlled trial of high dose inhaled corticosteroid. Arch Dis Child. 81:1999;38-44
36. Dahinden C.A., Kurimoto Y., De Weck A.L., Lindley I., Dewald B., Baggiolini M. The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils. J Exp Med. 170:1989;1787-1792
37. White M.V., Yoshimara T., Hook W., Kaliner M.A., Leonard E.J. Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release. Immunol Lett. 22:1989;151-154
38. Chung K., Barnes P. Cytokines in asthma. Thorax. 54:1999;825-857
39. Choudry N.B., Fuller R.W., Pride N.B. Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. Am Rev Respir Dis. 140:1989;137-141
40. Meijer R.J., Postma D.S., Kauffman H.F., Arends L.R., Koeter G.H., Kerstjens H.A.M. Accuracy of eosinophils and eosinophilic cationic protein to predict steroid improvement in asthma. Clin Exp Allergy. 32:2002;1096-1103
41. Aziz I., Wilson A.M., Lipworth B.J. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic subjects. Chest. 118:2000;1049-1058
42. Fujimoto K., Kubo K., Yamamoto H., Yamaguchi S., Matsuzawa Y. Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema. Chest. 115:1999;697-702
43. O'Shaughnessy K.M., Wellings R., Gillies B., Fuller R.W. Differential effects of fluticasone propionate on allergen-induced bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis. 147:1993;1472-1476
44. Little S., Chalmers G., MacLeod K., McSharry C., Thomson N. Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax. 55:2000;232-234
45. Jatakanon A., Lim S., Kharitonov S., Chung K., Barnes P. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax. 53:1998;91-95
46. Paredi P., Shah P., Montuschi P., Sullivan P., Hodson M., Kharitonov S., et al. Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax. 54:1999;917-920